Active Addictive Behavior Clinical Trials

10
Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans
Disease/Condition: Active Ethanol and Active Iomazenil | Active Ethanol and Placebo Iomazenil | Placebo Ethanol and Active Iomazenil | Placebo Ethanol and Placebo Iomazenil
Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors
Disease/Condition: Schizophrenia | Smoking
Principal Investigator: Kelly Cosgrove
Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment (ACCENT)
Disease/Condition: Cannabis Dependence
Principal Investigator: Kathleen Carroll
Cannabinoid Receptor Function & Alcoholism
Disease/Condition: Alcoholism
Principal Investigator: D'Souza, Deepak C.
Cannabinoids, Neural Synchrony, and Information Processing
Disease/Condition: Cannabis | Psychotic Disorders
Principal Investigator: D'Souza, Deepak C.
Chronic Alcohol and Brain Stress Circuit Response
Disease/Condition: Alcoholism | Stress
Principal Investigator: Rajita Sinha
Chronic Alcohol and Brain Stress Circuit Response
Disease/Condition: Alcoholism
Principal Investigator: Rajita Sinha
Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
Disease/Condition: Chronic Pain | Opiate Dependence
Principal Investigator: Richard Schottenfeld
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
Disease/Condition: Addiction
Principal Investigator: Mehmet Sofuoglu
Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment
Disease/Condition: Cognitive Impairment | Substance Abuse | Substance Dependence
Principal Investigator: Morris Bell
Computer Based Training in Cognitive Behavioral Therapy Web-based
Disease/Condition: Substance Abuse
Principal Investigator: Kathleen Carroll, PhD
Effects of Delta-9-THC and Iomazenil in Healthy Humans
Disease/Condition: Mental Disorders | Psychotic Disorders | Schizophrenia
Effects of Salvinorin A in Healthy Controls
Disease/Condition: Healthy
Establishing and eliminating cue-drug associations in human cocaine users
Disease/Condition: Cocaine Dependent Subjects
Principal Investigator: Robert Malison
Flavors and E-cigarette Effects in Adolescent Smokers
Disease/Condition: Nicotine Dependence, Cigarettes
Principal Investigator: Suchitra Krishnan-Sarin
FMRI of Stress and Addictive Disorders
Disease/Condition: Adolescents | Alcoholism | Cocaine Dependence | Opioid Dependence | Pathological Gamblers
Principal Investigator: Rajita Sinha, PhD
Galantamine Smoking Study
Disease/Condition: Nicotine Dependence
Principal Investigator: Mehmet Sofuoglu
Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 13C-MRS
Disease/Condition: Cocaine Dependence
Principal Investigator: Robert Malison
Guanfacine Clinical Trial for Smoking Cessation
Disease/Condition: Smoking Cessation
Principal Investigator: Sherry McKee
Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse
Disease/Condition: Alcohol Dependent | Cocaine Dependent
Principal Investigator: Rajita Sinha
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Disease/Condition: Cannabis Dependence | Family History of Alcoholism | Prodromal for Psychotic Illness | Schizophrenia
Principal Investigator: D. D'Souza
Implementation of HIT-Enhanced Tobacco Treatment for Hospitalized Smokers
Disease/Condition: Smoking Cessation
Principal Investigator: Steven Bernstein
Impulsivity and Stimulant Administration
Disease/Condition: Cocaine | Cocaine Dependence | Impulsivity
Principal Investigator: Robert Malison
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Disease/Condition: Alcoholism | Hepatitis C | HIV | Liver Diseases, Alcoholic
Principal Investigator: David Fiellin
Intravenous (IV) Nicotine Self Administration: Dose Ranging and Sex Differences in Smokers
Disease/Condition: Nicotine Addiction
Principal Investigator: Mehmet Sofuoglu, M.D,Ph.D.
Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism
Disease/Condition: Alcoholism
Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors
Disease/Condition: Alcohol Drinking
Principal Investigator: Suchitra Krishnan-Sarin
Ketamine/Placebo Family History Positive Study
Disease/Condition: Alcoholism
Principal Investigator: Petrakis, Ismene Leonida
Modafinil, Sleep Architecture and Cocaine Relapse
Disease/Condition: Cocaine Dependence
Principal Investigator: Peter Morgan
Modeling Stress-precipitated Smoking Behavior for Medication Development
Disease/Condition: Smoking
Principal Investigator: Sherry McKee
Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia
Disease/Condition: Opiate Dependence
Principal Investigator: Marek Chawarski
Naltrexone and Memantine Effects on Alcohol Drinking Behaviors
Disease/Condition: Alcohol Drinking
Principal Investigator: Suchitra Krishnan-Sarin
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations (New Hope)
Disease/Condition: AIDS | Drug Dependence | HIV | Opioid Dependency
Principal Investigator: Sandra Springer
New Approaches to Smoking Cessation in Heavy Drinkers
Disease/Condition: Alcohol Consumption | Cigarette Smoking | Heavy Drinking | Nicotine Dependence
Principal Investigator: Lisa Fucito, PhD
PET Imaging in Cocaine Self Administration
Disease/Condition: Cocaine Dependence
Principal Investigator: Robert Malison
Pharmacogenetics of Cannabinoid Response
Disease/Condition: COMT Gene Polymorphism
Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD)
Disease/Condition: Alcohol Dependence | Stress Disorders, Post-Traumatic
Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse
Disease/Condition: Alcohol Dependence
Principal Investigator: Rajita Sinha
Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
Disease/Condition: Reduction in Heavy Drinking in Patients With HIV
Principal Investigator: Lynn Fiellin
Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal
Disease/Condition: Cannabis Dependence
Principal Investigator: D. D'Souza
Sensitivity to Intravenous Nicotine: Genetic Moderators
Disease/Condition: Influence of OPRM1 A118G Status on Subjective Responses to IV Nicotine.
Test-retest Reproducibility of [11C]PHNO PET Using the Constant Infusion
Disease/Condition: Nicotine Dependence
Principal Investigator: Kelly Cosgrove
The Effects of ?-9-THC and Naloxone in Humans
Disease/Condition: Healthy
Principal Investigator: Deepak Cyril D''Souza
The Effects of Cannabidiol and ∆-9-THC in Humans
Disease/Condition: Healthy
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
Disease/Condition: Alcoholism
Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans
Disease/Condition: Cocaine Abuse
Principal Investigator: Robert Malison
Varenicline Treatment of Alcohol Dependent Smokers
Disease/Condition: Alcohol Abuse | Alcohol Dependence | Smoking
Principal Investigator: Stephanie O'Malley
Web-based CBT4CBT for Alcohol
Disease/Condition: Alcohol Abuse or Dependence
Principal Investigator: Kathleen Carroll